BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29138379)

  • 1. [A Case of Advanced Gastric Cancer Responding to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil, Leading to a Pathological Complete Response].
    Kawasaki K; Takeuchi D; Kaneko T; Miura S; Kamiya J; Miyahara Y; Yoshimura K; Ogata A
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):1017-1020. PubMed ID: 29138379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced gastric cancer exhibiting pathological complete response after neoadjuvant chemotherapy].
    Taniguchi M; Watanabe Y; Shirakawa M; Nakano H; Endo W; Hamano R; Tsujie M; Yano H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2298-300. PubMed ID: 24394091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial.
    Fazio N; Biffi R; Maibach R; Hayoz S; Thierstein S; Brauchli P; Bernhard J; Stupp R; Andreoni B; Renne G; Crosta C; Morant R; Chiappa A; Luca F; Zampino MG; Huber O; Goldhirsch A; de Braud F; Roth AD; ;
    Ann Oncol; 2016 Apr; 27(4):668-73. PubMed ID: 26712905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma.
    Guo Mg; Zheng Q; zhong Di J; Yang Z
    World J Surg Oncol; 2014 May; 12():150. PubMed ID: 24885421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in the treatment of T4 stage gastric cancer.
    Guo MG; Zheng Q; Cheng Z; Wang Y; Feng CN; Yang Z
    Surg Oncol; 2010 Mar; 19(1):1-3. PubMed ID: 19006661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.
    Sasaki K; Onodera S; Otsuka K; Satomura H; Kurayama E; Kubo T; Takahashi M; Ito J; Nakajima M; Yamaguchi S; Miyachi K; Kato H
    Med Oncol; 2017 Aug; 34(8):139. PubMed ID: 28707042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete regression after neoadjuvant chemotherapy in locally advanced gastric cancer causing peritonitis carcinomatosa--a case report].
    Ember A; Yousuf AF; Kalmár K; Papp A; Esik O; Horváth OP
    Magy Seb; 2006 Dec; 59(6):445-9. PubMed ID: 17432086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
    Tai Q; Shao H; Liu Y; Li E; Zhao R
    J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Simultaneous Multiple Gastric Cancers Showing Differences of Response after Neoadjuvant Chemotherapy with Docetaxel, CDDP, and S-1].
    Sakai T; Ichikawa H; Ishikawa T; Kosugi S; Hanyu T; Usui K; Muneoka Y; Otani T; Hishiki M; Nagahashi M; Sakata J; Kobayashi T; Kameyama H; Wakai T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2377-2379. PubMed ID: 28133327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer.
    Aoyama T; Nishikawa K; Fujitani K; Tanabe K; Ito S; Matsui T; Miki A; Nemoto H; Sakamaki K; Fukunaga T; Kimura Y; Hirabayashi N; Yoshikawa T
    Ann Oncol; 2017 Aug; 28(8):1876-1881. PubMed ID: 28486692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case.
    Watanabe T; Yoshikawa T; Kameda Y; Aoyama T; Hayashi T; Ogata T; Cho H; Tsuburaya A; Morita S; Miyashita Y; Sakamoto J
    Surg Today; 2012 Oct; 42(10):983-7. PubMed ID: 22398719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU].
    Matsutani T; Yoshida H; Sasajima K; Maruyama H; Yokoyama T; Matsushita A; Hirakata A; Takao Y; Umakoshi M; Hayakawa T; Katayama H; Hosone M; Uchida E
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):645-8. PubMed ID: 22504694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.
    Fushida S; Fujimura T; Oyama K; Kinoshita J; Fujita H; Ninomiya I; Ohta T
    Hepatogastroenterology; 2010; 57(104):1650-4. PubMed ID: 21443137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer.
    Yu YJ; Sun WJ; Lu MD; Wang FH; Qi DS; Zhang Y; Li PH; Huang H; You T; Zheng ZQ
    World J Gastroenterol; 2014 Dec; 20(48):18413-9. PubMed ID: 25561810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
    Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.
    Wang J; Xu R; Li J; Bai Y; Liu T; Jiao S; Dai G; Xu J; Liu Y; Fan N; Shu Y; Ba Y; Ma D; Qin S; Zheng L; Chen W; Shen L
    Gastric Cancer; 2016 Jan; 19(1):234-44. PubMed ID: 25604851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histological complete response in a case of primary squamous cell carcinoma of the stomach treated by chemotherapy with docetaxel and cisplatin plus 5-fluorouracil].
    Yanagisawa S; Tsuchiya S; Kaiho T; Togawa A; Shinmura K; Okamoto R; Nishimura M; Nomura S; Nobumoto D; Miyazaki M
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):307-10. PubMed ID: 20154491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative chemotherapy in locally advanced gastric cancer. A retrospective study about 25 cases.
    Ben Nasr S; Ayadi M; Bahloul R; Guesmi S; Allani B; Chrait N; Rifi H; Rais H; Mezlini A
    Tunis Med; 2015 Apr; 93(4):228-30. PubMed ID: 26375739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathological Complete Response of Advanced Gastric Cancer after Docetaxel and S-1 Combination Neoadjuvant Chemotherapy-A Case Report].
    Arisaka S; Kosaka R; Kunisaki C; Ichikawa Y; Akiyama H; Furuya M; Ohashi K; Endo I
    Gan To Kagaku Ryoho; 2016 Jul; 43(7):889-92. PubMed ID: 27431635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of advanced gastric cancer with bulky lymph node metastases responding to S-1/CDDP neoadjuvant chemotherapy and leading to less invasive surgery and a pathologically complete response].
    Eshita Y; Ogawa F
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):793-5. PubMed ID: 23863661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.